Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pasireotide as Maintenance Treatment With Monthly Deep Intramuscular Injection in SSTR2/3/5-Expressing Synovial Sarcoma and Desmoplastic Small Round Cell Tumor

NCT06456359 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.

NCT NCT06456359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06456359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pasireotide as Maintenance Treatment With Monthly Deep Intramuscular Injection in SSTR2/3/5-Expressing Synovial Sarcoma and Desmoplastic Small Round Cell Tumor
Lead sponsor
University Hospital Heidelberg
Phase
Phase 2
Overall status
Recruiting
Start date
December 19, 2024
Completion date
October 31, 2028
Enrollment
28 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

desmoplastic small round cell tumor, synovial sarcoma